Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions.
Klimas, Nancy G, Koneru, Anne O'Brien · Current rheumatology reports · 2007 · DOI
Quick Summary
Researchers studied what causes ME/CFS by looking at genes, immune cells, and hormones in patients. They found that how severe someone's initial viral infection was predicted whether fatigue would last long-term, and that people with ongoing ME/CFS show signs of reactivated viruses and problems with energy-producing structures in their cells. The immune system dysfunction they observed involved specialized infection-fighting cells not working properly.
Why It Matters
This study provides a comprehensive framework linking multiple biological abnormalities in ME/CFS—immune dysfunction, viral reactivation, and neuroendocrine dysregulation—which validates the disease as having objective biological basis rather than purely psychological origins. For patients, this work supports the rationale for developing targeted treatments aimed at specific immune and viral mechanisms rather than symptomatic management alone.
Observed Findings
Initial viral infection severity predicted persistent fatigue in prospective studies
Mitochondrial function abnormalities were identified in genomic studies
Natural killer and cytotoxic T cells show reduced intracellular perforin and granzyme levels
A subset of patients demonstrated evidence of viral reactivation
Inferred Conclusions
ME/CFS has distinct biological subtypes identifiable through gene microarray and immune profiling
Both initial infection characteristics and persistent viral reactivation contribute to disease pathogenesis
Immune cell cytotoxicity, HPA axis function, and mitochondrial integrity are interconnected biological targets for intervention
These mechanistic insights should guide development of subgroup-specific targeted therapies
Remaining Questions
Does initial infection severity directly cause immune dysregulation, or do pre-existing immune abnormalities predispose to persistent post-infectious fatigue?
Are identified viral gene expressions causally driving disease or representing bystander reactivation secondary to immune dysfunction?
What This Study Does Not Prove
This review does not establish causal mechanisms—whether viral reactivation causes immune dysfunction or vice versa remains unclear. It also does not identify which abnormalities are primary drivers versus secondary consequences of disease, and the proposed biomarkers lack established clinical utility or diagnostic validation. Gene expression correlations do not prove these abnormalities are therapeutically actionable.